# Kedplasma LLC – FDA Inspection, Mar 3, 2026

Source: https://www.keypedia.com/records/fda_inspections/kedplasma-llc/d213196a-cfcb-4f24-999a-1f5b73622c88
Source feed: FDA_Inspections

> FDA inspection 1305346 of Kedplasma LLC, March 03, 2026. 1 citation under 21 CFR part 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305346
- Company Name: Kedplasma LLC
- Inspection Date: 2026-03-03
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1096378 - 2019-06-06

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elyshia-q-danaher/73046c15-abb1-431e-8a76-59c7e8c1604a)

Company: https://www.keypedia.com/companies/kedplasma-llc/5008fd86-41ff-4937-8f01-5103fec34a6b

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9